427 results on '"Ruel, Nora"'
Search Results
102. MP47-12 COMPARISON OF PERIOPERATIVE OUTCOMES, FUNCTIONAL OUTCOMES, AND COMPLICATIONS FOR ROBOT ASSISTED RADICAL CYSTECTOMY WITH ORTHOTOPIC NEOBLADDER IN ELDERLY VS. YOUNG PATIENTS
103. Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
104. Integration of a Palliative Care Intervention into Community Practice for Lung Cancer: A Study Protocol and Lessons Learned with Implementation
105. Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy
106. Prospective randomised non‐inferiority trial of pelvic drain placement vs no pelvic drain placement after robot‐assisted radical prostatectomy
107. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy
108. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma
109. PD24-10 INTERIM ANALYSIS OF NCT02458716: FEASIBILITY OF CYTOREDUCTIVE PROSTATECTOMY IN MEN NEWLY DIAGNOSED WITH METASTATIC PROSTATE CANCER
110. MP03-16 UTILITY OF MULTI-PARAMETRIC MRI/ULTRASOUND FUSION: COGNITIVE NOT INFERIOR TO TARGETED SOFTWARE-BASED PROSTATE BIOPSIES
111. MP64-07 LYMPH NODE YIELD AND POSITIVITY RATE BY LOCATION IN 1000 ROBOTIC PROSTATECTOMY PATIENTS THAT UNDERWENT EXTENDED PELVIC LYMPH NODE DISSECTIONS AT A SINGLE INSTITUTION
112. PD18-11 PROSPECTIVE RANDOMIZED TRIAL OF PELVIC DRAIN PLACEMENT VERSUS NO PELVIC DRAIN PLACEMENT AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY (RARP)
113. PD06-11 FACTORS AFFECTING DELAYS IN NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY: AN ANALYSIS OF THE NATIONAL CANCER DATABASE COHORT
114. Ureteroenteric anastomotic revision as initial management of stricture after urinary diversion
115. Interim analysis of NCT02458716: Feasibility of cytoreductive prostatectomy in men newly diagnosed with metastatic prostate cancer.
116. Quality of life and self-management strategies after gastroesophageal cancer surgery.
117. PUB038 A Multimedia Self-Management Intervention to Prepare Patients and Family Caregivers for Lung Surgery
118. Wireless Real-Time Program Successfully Monitors Recovery after Major Abdominal Surgery
119. Family Caregiver Communication Tool: a new measure for tailoring communication with cancer caregivers
120. PD02-02 ENHANCED RECOVERY AFTER SURGERY AND CARE COORDINATION PATHWAY AT CITY OF HOPE: DECREASED LENGTH OF STAY, READMISSIONS, AND COMPLICATIONS
121. Recovery after surgery and care coordination pathway at City of Hope: Length of stay, readmissions, and complications.
122. Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy
123. Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma
124. Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer
125. Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study.
126. Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
127. Safety and efficacy of PIPAC in patients with ovarian cancer with peritoneal metastases: A first-in-US phase I study.
128. The effect of megestrol acetate ± pterostilbene in endometrial cancer: A prospective, randomized, window-of-opportunity clinical trial.
129. Biomarker analysis of a phase II trial of cabozantinib and erlotinib in patients (pts) with EGFR-mutant NSCLC with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance: A California Cancer Consortium Phase II Trial (NCI 9303).
130. Eribulin in advanced urothelial cancer (AUC) patients (pts): A California Cancer Consortium trial—NCI/CTEP 7435.
131. The Effect of Nerve-Sparing Robot-Assisted Radical Cystoprostatectomy on Erectile Function in a Preoperatively Potent Population
132. Effect of Alvimopan on Return of Bowel Function After Robot-Assisted Radical Cystectomy
133. Intermediate-Term Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Urothelial Carcinoma
134. Phase II trial of XL184 (cabozantinib) plus erlotinib in patients (pts) with advanced EGFR-mutant non-small cell lung cancer (NSCLC) with progressive disease (PD) on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy: A California Cancer Consortium phase II trial (NCI 9303).
135. NCI #8412: A randomized phase II trial of AZD6244 alone and AZD6244 plus temsirolimus for soft-tissue sarcomas.
136. NCI 8628: A randomized phase II study of ziv-aflibercept (Z) and high-dose interleukin-2 (HD IL-2) or HD IL-2 alone for inoperable stage III or IV melanoma—Efficacy and biomarker study.
137. Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).
138. CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
139. Radiation History Affects Continence Outcomes After AdVance Transobturator Sling Placement in Patients With Post-prostatectomy Incontinence
140. 1761 COMPLICATIONS OF ROBOTIC ASSISTED RADICAL CYSTECTOMY BY DIVERSION TYPE
141. 1493 VERY LOW RISK AND LOW RISK PROSTATE CANCER SURVIVAL AFTER ROBOTIC PROSTATECTOMY
142. Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy
143. Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
144. Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
145. 1810 ANALYSIS OF BIOCHEMICAL RECURRENCE BEYOND 5 YEARS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY
146. Analysis of regional lymph nodes in periprostatic fat following robot‐assisted radical prostatectomy
147. 659 LAPAROSCOPIC AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY IN CLINICALLY HIGH-RISK LOCALIZED PROSTATE CANCER AT A SINGLE INSTITUTION
148. 1350 PRIOR RADIATION AFFECTS CONTINENCE OUTCOMES FOLLOWING ADVANCE TRANSOBTURATOR SLING PLACEMENT IN PATIENTS WITH POST-PROSTATECTOMY INCONTINENCE
149. Abstract LB-275: 5-miRNA signature to predict clear cell renal cell carcinoma metastasis and prognosis
150. Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.